[Headlines Only] [Top Stories Only]
Categories
· Health/Science
· Cancer
non-USA, by Country
· Greece
· Cyprus

Zila to Begin Distributing Its Proprietary Oral Cancer Screening Product, ViziLite Plus, in Greece 

ompany Names Intertrade Dental as the Exclusive Distributor for Greece and Cyprus
Jump to full article: Business Wire, 2008-07-17

Intro:

Zila, Inc. (NASDAQ:ZILA) today announced that it has selected Intertrade Dental A.E.S.A. to be the exclusive distributor of ViziLite® Plus with TBlue™, Zila's proprietary oral cancer screening product, in Greece and Cyprus. Intertrade has placed orders for ViziLite Plus and plans to immediately begin training its sales representatives and preparing the market for the product launch. Terms of the agreement were not disclosed.

"ViziLite Plus will provide dental professionals in Greece and Cyprus with an effective screening tool in the fight against oral cancer,"

Jump to full article »